Diabetes Newsletter – December 2018

Print
   
www.berkshirewestdiabetes.org.uk December 2018
 
Monthly diabetes news for healthcare professionals and
others in Berkshire West


www.berkshirewestdiabetes.org.uk
 
     
  Berkshire West CCG win award at Eclipse National Conference  
 
At last month's annual Eclipse National Conference, Berkshire West CCG was recognised as the best performing CCG in the category "Best Monitoring in Diabetes". Over 50 CCGs use Eclipse nationally and Berkshire West achieved the highest percentage of diabetes patients (Type 1 & Type 2 together) being offered all eight National Diabetes Audit (NDA) care processes. This is an excellent performance, particularly considering that Berkshire West were the fifth worst performing PCT nationally in NDA 2011 out of over 200 PCTs.
 
In addition, Berkshire West CCG was second in the category "Effective Implementation in Diabetes" i.e. Treatment target achievement (again for T1 and T2 together). This is an area we have been concentrating on in recent years. 

I would like to thank all practice staff for their hard work in achieving this and also to our excellent secondary care colleagues.
 
The data was extracted in September this year and relates to the preceding 12 months.

Dr Paul Westcar, Berkshire West CCG Diabetes Lead
 
     
     
  NHS England’s announcement to provide glucose monitors for type 1 diabetes patients  
 
NHS England has recently announced that wearable glucose monitoring technology will be funded for people with Type 1 diabetes from 1 April 2019. This will come from next year’s funding growth for local health groups, which will allow access to flash monitoring throughout the country.

In September 2018, Berkshire West CCG approved an evaluation study to analyse the impact of Freestyle Libre on patient outcomes. This study is currently taking place at the Royal Berkshire NHS Foundation Trust.

Over the coming months, Berkshire West CCG will be awaiting further information from NHS England around implementation and having discussions with their providers about how the devices will be made available. The CCG will also need to include the provision of Freestyle Libre monitors in its financial plans for 2019/20.

The CCG’s current Freestyle Libre policy is available here. This will be reviewed and updated in line with the NHS England announcement.

Further information about NHS England’s announcement can be found here.
 
     
 
Diabetes Specialist Nurse Hotline: 07879 814922 (Monday to Friday 10am – 4pm) Consultant Hotline: 07717 867448. Email: virtualdiabetes@royalberkshire.nhs.uk
Visit our website: www.berkshirewestdiabetes.org.uk
Click here to read online